Thiogenesis Therapeutics Market Cap

Thiogenesis Therapeutics has a market cap or net worth of CAD 44.74 million as of August 14, 2025. Its market cap has increased by 40.50% in one year.

Market Cap

44.74M

Enterprise Value

41.73M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.80

Market Cap Chart

Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 44.74M, an increase of 220.63%. That is a compound annual growth rate of 41.79%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	44.74M	62.06%
Dec 31, 2024	27.61M	-17.40%
Dec 29, 2023	33.43M	48.30%
Dec 30, 2022	22.54M	61.52%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Curaleaf Holdings	2.87B
Green Thumb Industries	2.62B
Trulieve Cannabis	1.98B
Sienna Senior Living	1.75B
dentalcorp Holdings	1.61B
Cronos Group	1.35B
WELL Health Technologies	1.22B
Extendicare	1.11B

Market Cap Rankings